These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38766009)

  • 1. Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.
    Gai D; Caviness PC; Lazarenko OP; Chen JF; Randolph CE; Zhang Z; Cheng Y; Sun F; Xu H; Blackburn ML; Tricot G; Shaughnessy JD; Chen JR; Zhan F
    Res Sq; 2024 May; ():. PubMed ID: 38766009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.
    Gai D; Chen JR; Stewart JP; Nookaew I; Habelhah H; Ashby C; Sun F; Cheng Y; Li C; Xu H; Peng B; Garg TK; Schinke C; Thanendrarajan S; Zangari M; Chen F; Barlogie B; van Rhee F; Tricot G; Shaughnessy JD; Zhan F
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35881476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Magnitude Mechanical Signals Combined with Zoledronic Acid Reduce Musculoskeletal Weakness and Adiposity in Estrogen-Deprived Mice.
    Pagnotti GM; Trivedi T; Wright LE; John SK; Murthy S; Pattyn RR; Willis MS; She Y; Suresh S; Thompson WR; Rubin CT; Mohammad KS; Guise TA
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
    Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
    Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
    Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL
    J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
    Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
    J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.
    Liu Z; Liang W; Kang D; Chen Q; Ouyang Z; Yan H; Huang B; Jin D; Chen Y; Li Q
    Clin Interv Aging; 2020; 15():1201-1212. PubMed ID: 32764906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
    Sun F; Cheng Y; Chen JR; Wanchai V; Mery DE; Xu H; Gai D; Al Hadidi S; Schinke C; Thanendrarajan S; Zangari M; van Rhee F; Tricot G; Shaughnessy JD; Zhan F
    J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37883186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
    Henning P; Westerlund A; Movérare-Skrtic S; Lindholm C; Márquez-Méndez M; Nilsson S; Holmberg AR; Lerner UH
    Invest New Drugs; 2024 Apr; 42(2):207-220. PubMed ID: 38427117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
    Kodama I; Niida S; Sanada M; Yoshiko Y; Tsuda M; Maeda N; Ohama K
    J Bone Miner Res; 2004 Feb; 19(2):200-6. PubMed ID: 14969389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.
    Ma L; Zhang L; Liao Z; Xiu C; Luo X; Luo N; Zhang L; He G; Chen J
    J Orthop Translat; 2023 Sep; 42():1-14. PubMed ID: 37521493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study.
    Li G; Zhang L; Wang L; Yuan G; Dai K; Pei J; Hao Y
    Acta Biomater; 2018 Jan; 65():486-500. PubMed ID: 29079514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (S)-Equol Is More Effective than (R)-Equol in Inhibiting Osteoclast Formation and Enhancing Osteoclast Apoptosis, and Reduces Estrogen Deficiency-Induced Bone Loss in Mice.
    Tanaka M; Fujii S; Inoue H; Takahashi N; Ishimi Y; Uehara M
    J Nutr; 2022 Aug; 152(8):1831-1842. PubMed ID: 35675296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
    Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
    Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
    J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.
    Zhou S; Zilberman Y; Wassermann K; Bain SD; Sadovsky Y; Gazit D
    J Cell Biochem Suppl; 2001; Suppl 36():144-55. PubMed ID: 11455579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
    Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
    J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.